COMMUNIQUÉS West-GlobeNewswire
-
Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI®▼ (teclistamab) plus DARZALEX® (daratumumab) subcutaneous formulation as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
09/12/2025 -
Olympia Pharmaceuticals and Wesley Pharmaceuticals Co-Founder Stan Loomis Establishes Scholarship for The Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health
09/12/2025 -
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China
09/12/2025 -
UPDATE -- Tessera Therapeutics Announces Chief Financial Officer (CFO) Transition and Appointment of Kathy Bergsteinsson as CFO
09/12/2025 -
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
09/12/2025 -
Young Americans Lead in HSA Adoption But Carry Heaviest Economic Burden, HealthEquity Research Finds
09/12/2025 -
Meiogenix Forms Strategic Advisory Board of Global AgTech Leaders to Accelerate Crop Breeding Transformation
09/12/2025 -
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
09/12/2025 -
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN
09/12/2025 -
Dandy Acquires Neem to Accelerate Digital Innovation in Dentistry
09/12/2025 -
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
09/12/2025 -
Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning
09/12/2025 -
Novo Nordisk has completed its acquisition of Akero Therapeutics
09/12/2025 -
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer
09/12/2025 -
Clene to Present at the Emerging Growth Conference
09/12/2025 -
Cedar Gate Introduces Next-Generation Solutions for Prospective Bundled Payment Models
09/12/2025 -
Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing
09/12/2025 -
Aprea Therapeutics Announces $3.1 Million Private Placement Priced At-The-Market Under Nasdaq Rules
09/12/2025 -
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic Shift and Unlock Value, Backed by Additional Investment
09/12/2025
Pages